A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

Những quyển sách tương tự

• Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
  Bằng: Jin, Xuan, et al.
  Được phát hành: (2020)
• The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
  Bằng: Rhee, Moo-Yong, et al.
  Được phát hành: (2017)
• Evaluation of stability and simultaneous determination of fimasartan and amlodipine by a HPLC method in combination tablets
  Bằng: Hyeon Woo Moon, et al.
  Được phát hành: (2014-06-01)
• Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy
  Bằng: Rhee, Moo-Yong, et al.
  Được phát hành: (2015)
• Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
  Bằng: Kang, Woo Youl, et al.
  Được phát hành: (2018)